Pharnext executes a financing agreement with -5-

DJ Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A Pharnext Pharnext executes a financing agreement

Related Keywords

Paris ,France General ,France ,United States ,Matignon ,Bretagne ,French ,America ,Pharnext ,Bloomberg ,Company Of The Extraordinary ,Euronext Growth Stock Exchange ,Bonds ,French Regulatory News ,Global Techopportunities ,Alpha Blue Ocean ,Financing Agreement ,Bonds Tranches ,Dow Jones Newswires ,Chief Executive Officer ,Extraordinary General Meeting ,Equitis Gestion ,David Horn Solomon ,Horn Solomon ,Press Relations ,Financial Communications ,Consilium Strategic Communications ,Ulysse Communication ,Mary Jane Elliott ,Bruno Arabian ,Ghislaine Gasparetto ,Sukaina Virji ,Alexandra Harrison ,Loan Agreement ,Executes ,Financing ,Agreement ,